Fidaxomicin for Clostridium difficile-Associated Diarrhoea

David A. Sclar,Linda M. Robison,Ambartsum M. Oganov,Jennifer M. Schmidt,Kurt A. Bowen,Leigh V. Castillo

Fidaxomicin for Clostridium difficile-Associated Diarrhoea

2012

David A. Sclar
Linda M. Robison
Ambartsum M. Oganov
Jennifer M. Schmidt
Kurt A. Bowen
Leigh V. Castillo

Background: Fidaxomicin is a macrocyclic antibiotic approved in 2011 by the US Food and Drug Administration for treatment of Clostridium difficile-associated diarrhoea (CDAD).

Keywords:

Intensive care medicine
Anesthesia
Medicine
Antibiotics
Fidaxomicin
Microbiology
Clostridium
Vancomycin
food and drug administration
Internal medicine
pharmacology toxicology
Pharmacotherapy
clostridium difficile

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations